The evidence and impact of deprescribing on sarcopenia parameters: a systematic review

The evidence and impact of deprescribing on sarcopenia parameters: a systematic review

Abstract Background Polypharmacy (concomitant prescription of ≥ 5 medications) affects a third of older people, and evidence suggests an association with sarcopenia (loss of skeletal muscle mass/quality, muscle strength, and/or physical performance). As such, deprescribing has been recommended in ro...

Full description

Saved in:
Bibliographic Details
Main Authors: Kinda Ibrahim, Natalie J. Cox, Stephen E. R. Lim, Eloise Radcliffe, Carina Lundby, Konstantinos Prokopidis, Wade Thompson, Frank Moriarty
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Geriatrics
Subjects:
Sarcopenia
Deprescribing
Muscle strength
Muscle mass
Muscle function
Outcomes
Online Access:https://doi.org/10.1186/s12877-025-05819-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12877-025-05819-7

Similar Items